ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 1894 • ACR Convergence 2023

    3-Dimensional Regional Variation in Inter-rater Reliability of Bone Marrow Lesion Scoring in the Knee

    Stephanie Wichuk1, Walter P. Maksymowych1, Joel Paschke2, Abhilash Hareendranathan3 and Jacob Jaremko1, 1University of Alberta, Edmonton, AB, Canada, 2CARE Arthritis, Edmonton, AB, Canada, 3Radiology and Diagnostic Imaging, Edmonton, AB, Canada

    Background/Purpose: Bone marrow lesions (BML) are an important scoring feature on magnetic resonance imaging (MRI) of knee osteoarthritis (OA), and their presence in certain anatomical…
  • Abstract Number: 2424 • ACR Convergence 2023

    Exploring the Limit of Image Resolution for Human Expert Classification of Vascular Ultrasound Images in Giant Cell Arteritis and Healthy Subjects: The GCA-US-AI Project

    Valentin Sebastian Schäfer1, Stavros Chrysidis2, Christian Dejaco3, Sara Monti4, Matthew Koster5, Pantelis Karakostas1, Wolfgang Schmidt6, Eugenio De Miguel7, Christina Duftner8, Alojzija Hocevar9, Annamaria Iagnocco10, Marcin Milchert11, Chetan Mukhtyar12, Cristina Ponte13, Lene Terslev14, Tanaz Kermani15, Uffe Møller Døhn16, Berit Dalsgaard Nielsen17, Aaron Juche18, Luca Seitz19, Minna Kohler20, Kresten Keller21, Rositsa Karalilova22, Thomas Daikeler23, Sarah Mackie24, Karina Torralba25, Kornelis van der Geest26, Dennis Boumans27, Philipp Bosch28, Alessandro Tomelleri29, Markus Aschwanden30, Peter Brossart1, Charlotte Behning31 and Claus Juergen Bauer1, 1Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, Bonn, Germany, 2Department of Rheumatology, Southwest Jutland Hospital Esbjerg, Esbjerg, Denmark, 3Department of Rheumatology, Medical University Graz, Graz, Austria; Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy, 4Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy, 5Mayo Clinic, Rochester, MN, 6Rheumatology, Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, 7Hospital Universitario La Paz, Madrid, Spain, 8Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria, 9Department of Rheumatology, Universitiy Medical Centre Ljubljana, Ljubljana, Slovenia, 10University of Turin, Roma, Italy, 11Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Szczecin, Poland, 12Vasculitis service, Rheumatology department, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 13Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 14Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 15Rheumatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 16Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, 17Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark; Department of Medicine, The Regional Hospital in Horsens, Horsens, Denmark, 18Department of Rheumatology, Immanuel Hospital, Berlin, Germany, 19Rheumatology and Immunology, Inselspital University Hospital Bern, Bern, Switzerland, 20Massachusetts General Hospital, Harvard Medical School, Boston, MA, 21Department of Rheumatology, Aarhus University Hospital; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 22Clinic of Rheumatology, Medical University Plovdiv, Plovdiv, Bulgaria, 23Clinic for Rheumatology, University Hospital Basel, Basel, Switzerland, 24Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 25Division of Rheumatology, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, CA, 26Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 27Rheumatology and Clinical Immunology, Hospital Group Twente, Almelo, Netherlands, 28Medical University of Graz, Graz, Austria, 29Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milano, Italy, 30Department of Angiology, University Hospital Basel, Basel, Switzerland, 31Institute of Medical Biometry, Informatics and Epidemiology, University Hospital of Bonn, Bonn, Germany

    Background/Purpose: Giant cell arteritis (GCA) is the most common form of vasculitis in adults, necessitating prompt diagnosis to prevent severe complications. However, access to expert…
  • Abstract Number: 0923 • ACR Convergence 2023

    Identification of Lupus Nephritis Kidney Immune Populations via Hi-Resolution 20-Plex Immunohistochemistry Single-Cell Spatial Analyses

    Caleb Marlin1, Alessandra Ida Celia2, Richard Furie3, Judith James1, Andrea Fava4, Joel Guthridge1, Avi Rosenberg5, Tayte Stephens1, Christian Wright1, Jeff Hodgin6, Peter Izmirly7, H Michael Belmont8, Jennifer Anolik9, Michelle Petri10, Jill Buyon11, Diane L. Kamen12, Chaim Putterman13, Accelerating Medicines Partnership in RA/SLE The1, Chen-Yu Lee4 and Xiaoping Yang4, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2John Hopkins University of Medicine, Rome, Italy, 3Northwell Health, Manhasset, NY, 4Johns Hopkins University, Baltimore, MD, 5Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, 6University of Michigan, Ann Arbor, MI, 7New York University School of Medicine, New York, NY, 8NYU School of Medicine, New York, NY, 9University of Rochester Medical Center, Rochester, NY, 10Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Timonium, MD, 11NYU Grossman School of Medicine, New York, NY, 12Medical University of South Carolina, Charleston, SC, 13Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Immunohistochemistry is the gold standard for antibody staining in microscopy. However, a lack of multiplexing limits its utility in the use of discovery. Here…
  • Abstract Number: 1195 • ACR Convergence 2023

    Relationship of Depth-Specific Subchondral Bone Mineral Density to MRI Cartilage Worsening: The Multicenter Osteoarthritis Study

    Jean Liew1, JD Johnston2, Gabriela Rabasa1, Beth Lewis3, John Lynch4, James Torner5 and Tuhina Neogi6, 1Boston University, Boston, MA, 2University of Saskatchewan, Saskatoon, SK, Canada, 3University of Alabama at Birimingham, Birmingham, AL, 4University of California San Francisco, San Francisco, CA, 5University of Iowa, Iowa City, IA, 6Boston University School of Medicine, Boston, MA

    Background/Purpose: While OA has been considered a disease of cartilage, early subchondral bone changes may precede cartilage abnormalities. Although higher systemic BMD has a known…
  • Abstract Number: 1690 • ACR Convergence 2023

    Apremilast Reduces Inflammation as Measured by MRI of the Hand in Patients with Psoriatic Arthritis: Primary Results from the Phase 4 MOSAIC Study

    Mikkel Østergaard1, Walter P. Maksymowych2, Mikael Boesen3, Robert Lambert4, Guillermo Valenzuela5, Michael Bubb6, Olga Kubassova7, Jyotsna Reddy8, Stephen Colgan9, Yuri Klyachkin10, Cynthia Deignan11, Lihua Tang8, Maria Paris8 and Philip J. Mease12, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; University of Copenhagen, Copenhagen, Denmark, 2University of Alberta, Edmonton, AB, Canada, 3Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Naerum, Denmark, 4Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 5Integral Rheumatology & Immunology Specialists, Plantation, FL, 6University of Florida, Gainesville, FL, 7Image Analysis Group, Philadelphia, PA, 8Amgen, Inc., Thousand Oaks, CA, 9Amgen, Inc., Halton Hills, ON, Canada, 10Amgen, Inc., Lexington, KY, 11Amgen, Inc., Agoura Hills, CA, 12Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA

    Background/Purpose: PsA is characterized by inflammatory arthritis, enthesitis, dactylitis, and spondylitis. Apremilast (APR) is an oral immunomodulating phosphodiesterase-4 inhibitor approved for the treatment of PsA.…
  • Abstract Number: 1926 • ACR Convergence 2023

    Use of 18F-FDG PET in Assessing Response to Treatment in Adults with Pulmonary Sarcoidosis: A Systematic Literature Review

    Koushan Kouranloo1, Mathangi Krishnakumar2 and Mrinalini Dey3, 1Rheumatology & Internal Medicine Trainee- Surrey, UK. Education fellow University of Liverpool, Liverpool, United Kingdom, 2Wrexham Maelor Hospital, Wrexham, United Kingdom, 3Queen Elizabeth Hospital, London, United Kingdom; University of Liverpool, Liverpool, United Kingdom

    Background/Purpose: Sarcoidosis is a chronic, multisystem, granulomatous disease commonly affecting the lungs. Immunosuppressants, particularly corticosteroids, are the mainstay of treatment. Symptoms, severity and response to…
  • Abstract Number: 2436 • ACR Convergence 2023

    Characterizing Spatial Organization of Immune Infiltrates in Rheumatoid Arthritis Synovia Using Spatial Transcriptomic Analysis

    Roopa Madhu1, Kartik Bhamidipati1, Anna Helena Jonsson1, Fan Zhang2, Lucy MacDonald3, Youngmi Kim4, Yi Cui4, STARS BWH1, Accelerating Medicines Partnership Program RA SLE Network5, Mariola Kurowska-Stolarska3, Stefano Alvernini6, Ellen Gravallese7, Michael Brenner7, Soumya Raychaudhuri1, Kevin Wei7 and ilya Korsunsky1, 1Brigham and Women's Hospital, Boston, MA, 2University of Colorado, Aurora, CO, 3Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, Glasgow, United Kingdom, 4Nanostring, Seattle, WA, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6Division of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by immune infiltration of the synovial tissue lining joints. RA is clinically heterogenous, with patients having…
  • Abstract Number: 0939 • ACR Convergence 2023

    HRCT-derived Delta Radiomic Features Classify Response to Anti-Fibrotic Treatment in Experimental and Human Fibrosing Interstitial Lung Disease

    David Lauer1, Luca Romano Kolly1, Hubert Gabrys2, Matthias Brunner1, Malgorzata Anna Maciukiewicz1, Thomas Frauenfelder3, Stephanie Tanadini-Lang2, Anne-Christine Uldry4, Manfred Heller4, Kerstin Klein5, Oliver Distler6, Janine Gote-Schniering1 and Britta Maurer7, 1University Hospital Bern, Bern, Switzerland, 2University Hospital Zurich, Zurich, Switzerland, 3Dept of Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 4University of Bern, Bern, Switzerland, 5Department of Rheumatology and Immunology, University Hospital Bern, Bern, Switzerland, 6Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7University Hospital Bern, University Bern, Bern, Switzerland

    Background/Purpose: Quantification of response to anti-fibrotic drugs in patients with fibrosing interstitial lung disease (ILD) relies on repeated pulmonary function tests (PFT) and visual evaluation…
  • Abstract Number: 1286 • ACR Convergence 2023

    Impact of Body Mass Index (BMI) on Upper versus Lower Extremity Joints Assessed Using Clinical and Musculoskeletal Ultrasound Measures in Rheumatoid Arthritis Patients

    Nicolette Morris1, Elena Saab2, Lucia Chen1, Jenny Brook1, Gurjit S Kaeley3, David Elashoff1 and Veena Ranganath1, 1David Geffen School of Medicine, UCLA, Los Angeles, CA, 2Wake Forest University School of Medicine, Los Angeles, CA, 3University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Tender and swollen joints counts may be differentially affected in rheumatoid arthritis (RA) patients with obesity. A prior study demonstrated an association between increased…
  • Abstract Number: 1716 • ACR Convergence 2023

    High-Throughput Semi-Automated Micro-CT Analysis Identifies the Cuboid Bone as a Sex-Dependent Biomarker of Inflammatory-Erosive Arthritis in TNF-Tg Mice

    H. Mark Kenney1, Kiana Chen2, Lindsay Schnur3, Jeffrey Fox3, Ronald Wood3, Lianping Xing4, Christopher T Ritchlin5, Homaira Rahimi6, Edward Schwarz6 and Hani Awad3, 1University of Rochester School of Medicine and Dentistry, Henrietta, NY, 2University of Rochester School of Medicine and Dentistry, Rochester, NY, 3University of Rochester Medical Center, Rochester, NY, 4University of Rochester Medical Center, Webster, NY, 5University of Rochester Medical School, Allergy, Immunology & Rheumatology Division, Canandaigua, NY, 6University of Rochester, Rochester, NY

    Background/Purpose: Development of reliable disease activity biomarkers is critical for diagnostics, prognostics, and novel drug development. In the case of preclinical models of inflammatory-erosive arthritis,…
  • Abstract Number: 1959 • ACR Convergence 2023

    Quantitative Scoring of High Resolution Chest Computed Tomography (HRCT) Images in Myositis and Antisynthetase Syndrome Related Interstitial Lung Disease in Comparison to Scleroderma Related Interstitial Lung Disease

    Sangmee Bae1, Fereidoun Abtin2, Grace Kim3, Siamak Moghadam-Kia4, Chester V. Oddis5, Lila Pourzand2, Didem Saygin5, Daniel Sullivan6, Koichi Yamaguchi7, Donald Tashkin3, Christina Charles-Schoeman8, Jonathan Goldin3 and Rohit Aggarwal5, 1UCLA Rheumatology, Los Angeles, CA, 2UCLA Radiological Sciences, Los Angeles, CA, 3University of California Los Angeles, Los Angeles, CA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA, 6UCLA Pulmonology, Pittsburgh, PA, 7University of Pittsburgh Medical Center Rheumatology, Pittsburgh, PA, 8UCLA Medical Center, Santa Monica, CA

    Background/Purpose: High resolution computed tomography (HRCT) of the chest has become an important modality in the evaluation of interstitial lung disease (ILD). A quantitative CT…
  • Abstract Number: 2525 • ACR Convergence 2023

    Comparing Patellar Tendon Characteristics Between Adults with and Without Knee Pain

    Samantha Price1, Karin Silbernagel2, David Felson3, Joshua Stefanik4 and Patrick Corrigan1, 1Saint Louis University, St. Louis, MO, 2University of Delaware, Avondale, PA, 3Boston University, Boston, MA, 4Northeastern University, Boston, MA

    Background/Purpose: Knee pain is one of the most common types of joint pain leading to disability, limited physical activity, and reduced quality of life. While…
  • Abstract Number: 029 • 2023 Pediatric Rheumatology Symposium

    Cardiac Magnetic Resonance Imaging in Children with Systemic Lupus Erythematosus and Scleroderma Spectrum Disorders: A Single Center Experience

    Meredith Rae, Tam Doan and Eyal Muscal, Baylor College of Medicine, Houston, TX

    Background/Purpose: Cardiac disease is a major cause of morbidity and mortality in children with SLE and SSc. Various studies have demonstrated an association between duration…
  • Abstract Number: 0479 • ACR Convergence 2022

    A Prospective Study Evaluating the Utility of Ultrasound in Monitoring Newly-Diagnosed GCA

    Colm Kirby1, Rachael Flood1, Ronan Mullan1, Grainne Murphy2 and David Kane1, 1Tallaght University Hospital, Dublin, Ireland, 2Cork University Hospital, Cork, Ireland

    Background/Purpose: In recent years, Temporal Artery US (TAUS) has become a reliable alternative to biopsy for diagnosing GCA. However, normalisation of pathologic findings have been…
  • Abstract Number: 1244 • ACR Convergence 2022

    Incidence of Radiographic Spinal Damage in Psoriatic Arthritis Patients Compared to Spondyloarthritis Patients: Which Patients Are More Affected?

    Manouk de Hooge1, Alla Alexeevna Ishchenko2, Ann-Sophie Kathleen De Craemer3, Serge Steinfeld4, Adrien NZEUSSEU TOUKAP5, Filip Van den bosch6, Dirk Elewaut7, Rik Lories8 and Kurt de Vlam9, 1Ghent University Hospital, Luxembourg, Luxembourg, 2University Hospitals Leuven, Sint-Stevens-Woluwe, Belgium, 3Ghent University Hospital, Gent, Belgium, 4Clinique Saint-Jean, Brussels, Belgium, 5Cliniques Universitaires Saint-Luc, Brussels, Belgium, 6Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium, 7Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium, 8KU Leuven, Leuven, Belgium, 9University Hospitals Leuven, Leuven, Belgium

    Background/Purpose: There is an ongoing debate on axial involvement in psoriatic arthritis (PsA) patients. This study reports the baseline radiographic spinal damage in PsA and…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology